Breaking News

Amgen Selects West’s SmartDose Delivery Platform

On-body infusor with prefilled cartridge to deliver monthly single dose of Repatha

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Amgen has received FDA approval for a single, monthly 420 mg dose delivery option for Repatha (evolocumab), using West Pharmaceutical Services’ SmartDose technology.   “West is very pleased that Amgen has selected the SmartDose technology platform for the new monthly single dose administration option of Repatha,” said Eric M. Green, president and chief executive officer, West. “The combination of Amgen’s innovative treatment with West’s patient-focused technology ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters